<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2025-23-99-102</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-4668</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Перспективы применения физиотерапевтических методов в терапии телогеновой алопеции</article-title><trans-title-group xml:lang="en"><trans-title>Prospects for the use of physiotherapy methods in the treatment of telogen alopecia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-6213-9496</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Безбородова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bezborodova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Безбородова Анна Владимировна, аспирант кафедры дерматовенерологии и косметологии E‑mail: </p><p>Москва</p></bio><bio xml:lang="en"><p>Bezborodova Anna V., postgraduate student at Dept of Dermatovenereology and Cosmetology</p><p>Moscow </p></bio><email xlink:type="simple">bezborodova98@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0238-6563</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шатохина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shatokhina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шатохина Евгения Афанасьевна, д.м.н., профессор кафедры дерматовенерологии и  косметологии; ведущий научный сотрудник отдела внутренних болезней</p><p>Москва</p></bio><bio xml:lang="en"><p>Shatokhina Evgeniya A., DM Sci (habil.), professor at Dept of Dermatovenereology and Cosmetology; leading researcher at Dept of Internal Medicine</p><p>Moscow</p></bio><email xlink:type="simple">e.a.shatokhina@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8562-1778</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терентьева</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Terentieva</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Терентьева Лада Владимировна, к.м.н., доцент кафедры </p><p>Москва </p></bio><bio xml:lang="en"><p>Terentieva Lada V., PhD Med, associate professor at Dept</p><p>Moscow</p></bio><email xlink:type="simple">t.lada@inbox.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Department of the President of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации;&#13;
ФГБОУ ВО «Московский государственный университет имени М.В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Department of the President of the Russian Federation;&#13;
Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Кафедра дерматовенерологии имени академика Ю.К. Скрипкина Института клинической медицины ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава России (Пироговский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Dermatovenerology named after Academician Yu.K. Skripkin of Institute of Clinical Medicine at N.I. Pirogov Russian National Research Medical University (Pirogov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>11</day><month>11</month><year>2025</year></pub-date><volume>1</volume><issue>23</issue><issue-title>Дерматология (2)</issue-title><fpage>99</fpage><lpage>102</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Безбородова А.В., Шатохина Е.А., Терентьева Л.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Безбородова А.В., Шатохина Е.А., Терентьева Л.В.</copyright-holder><copyright-holder xml:lang="en">Bezborodova A.V., Shatokhina E.A., Terentieva L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/4668">https://www.med-alphabet.com/jour/article/view/4668</self-uri><abstract><p>Телогеновая алопеция (ТА) – это одно из наиболее распространенных заболеваний, сопровождающихся потерей волос. Основной патогенетический механизм ТА заключается в преждевременном переходе волосяных фолликулов из фазы анагена в фазу телогена. В условиях отсутствия единого стандарта лечения особый интерес представляют физиотерапевтические методы, направленные на активацию роста волос за счёт стимуляции клеточной активности и энергетического метаболизма. Одним из наиболее перспективных методов признана низкоинтенсивная лазерная терапия, которая способствует увеличению синтеза АТФ и активации сигнальных путей, регулирующих рост и дифференцировку клеток волосяных фолликулов. Высокоинтенсивные абляционные и неабляционные лазеры не только стимулируют рост волос, но и улучшают трансдермальную доставку препаратов. Наряду с этим, методы с применением радиочастотного и электрического воздействия усиливают клеточную пролиферацию, экспрессию факторов роста и процессы тканевой регенерации. Научные исследования подтверждают эффективность этих методов и демонстрируют перспективность их применения как в монотерапии, так и в комбинированных протоколах. Таким образом, физиотерапевтические технологии открывают возможности для создания патогенетически обоснованных методов лечения телогеновой алопеции.</p></abstract><trans-abstract xml:lang="en"><p>Telogen effluvium (TE) is one of the most common diseases accompanied by hair loss. The main pathogenetic mechanism of TE is the premature transition of hair follicles from the anagen phase to the telogen phase. In the absence of a single standard treatment, physiotherapeutic methods aimed at activating hair growth by stimulating cell activity and energy metabolism are of particular interest. One of the most promising methods is low-intensity laser therapy, which promotes increased ATP synthesis and activation of signalling pathways that regulate the growth and differentiation of hair follicle cells. High‑intensity ablative and non‑ablative lasers not only stimulate hair growth but also improve transdermal drug delivery. In addition, methods using radiofrequency and electrical stimulation enhance cell proliferation, growth factor expression and tissue regeneration processes. Scientific studies confirm the effectiveness of these methods and demonstrate their potential for use in both monotherapy and combined protocols. Thus, physiotherapeutic technologies open up opportunities for the creation of pathogenetically sound methods for the treatment of telogen alopecia.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>телогеновая алопеция</kwd><kwd>физиотерапевтические методы</kwd><kwd>низкоинтенсивная лазерная терапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>telogen alopecia</kwd><kwd>physiotherapy methods</kwd><kwd>low‑intensity laser therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Asghar F. et al. Telogen effluvium: a review of the literature // Cureus.– 2020.–V. 12.– № . 5.</mixed-citation><mixed-citation xml:lang="en">Asghar F. et al. Telogen effluvium: a review of the literature // Cureus.– 2020.–V. 12.– № 5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Glass G.E. Photobiomodulation: the clinical applications of low level light therapy // Aesthetic surgery journal.– 2021.– V. 41.– № . 6.– P. 723–738.</mixed-citation><mixed-citation xml:lang="en">Glass G.E. Photobiomodulation: the clinical applications of low level light therapy // Aesthetic surgery journal.– 2021.– V. 41.– № . 6.– P. 723–738.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta A.K., Foley K.A. A critical assessment of the evidence for low level laser therapy in the treatment of hair loss //Dermatologic Surgery.– 2017.– V. 43.– № . 2.– P. 188–197.</mixed-citation><mixed-citation xml:lang="en">Gupta A.K., Foley K.A. A critical assessment of the evidence for low level laser therapy in the treatment of hair loss //Dermatologic Surgery.– 2017.– V. 43.– № . 2.– P. 188–197.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Couturaud V. et al. Reverse skin aging signs by red light photobiomodulation //Skin Research and Technology.– 2023.– V. 29.– № . 7.– P. e13391.</mixed-citation><mixed-citation xml:lang="en">Couturaud V. et al. Reverse skin aging signs by red light photobiomodulation //Skin Research and Technology.– 2023.– V. 29.– № . 7.– P. e13391.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chung H. et al. The nuts and bolts of low level laser (light) therapy // Annals of biomedical engineering.– 2012.– V. 40.– P. 516–533.</mixed-citation><mixed-citation xml:lang="en">Chung H. et al. The nuts and bolts of low level laser (light) therapy // Annals of biomedical engineering.– 2012.– V. 40.– P. 516–533.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Звездина И.В., Исаева С.Г., Ляпон А.О. Новый взгляд на терапию хронической идиопатической диффузной телогеновой алопеции у женщин // Доктор. ру.– 2015.– № . 7 (108).– С. 42–46</mixed-citation><mixed-citation xml:lang="en">Zvezdina I.V., Isaeva S.G., Lyapon A.O. A New Perspective on the Treatment of Chronic Idiopathic Diffuse Telogen Alopecia in Women // Doctor.Ru.– 2015.– No. 7 (108).– P. 42–46. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Han L. et al. Activation of Wnt/β catenin signaling is involved in hair growth promoting effect of 655 nm red light and LED in in vitro culture model // Lasers in medical science.– 2018.– V. 33.– P. 637–645.</mixed-citation><mixed-citation xml:lang="en">Han L. et al. Activation of Wnt/β catenin signaling is involved in hair growth promoting effect of 655 nm red light and LED in in vitro culture model // Lasers in medical science.– 2018.– V. 33.– P. 637–645.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Choi B.Y. Targeting Wnt/β catenin pathway for developing therapies for hair loss // International journal of molecular sciences.– 2020.– V. 21.– № . 14.– P. 4915.</mixed-citation><mixed-citation xml:lang="en">Choi B.Y. Targeting Wnt/β catenin pathway for developing therapies for hair loss // International journal of molecular sciences.– 2020.– V. 21.– № . 14.– P. 4915.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dejana E. The role of wnt signaling in physiological and pathological angiogenesis //Circulation research.– 2010.– V. 107.– № . 8.– P. 943–952.</mixed-citation><mixed-citation xml:lang="en">Dejana E. The role of wnt signaling in physiological and pathological angiogenesis //Circulation research.– 2010.– V. 107.– № . 8.– P. 943–952.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Liu K.H. et al. Comparative effectiveness of low level laser therapy for adult androgenic alopecia: a system review and meta analysis of randomized controlled trials //Lasers in Medical Science.– 2019.– V. 34.– P. 1063–1069.</mixed-citation><mixed-citation xml:lang="en">Liu K.H. et al. Comparative effectiveness of low level laser therapy for adult androgenic alopecia: a system review and meta analysis of randomized controlled trials //Lasers in Medical Science.– 2019.– V. 34.– P. 1063–1069.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ke J. et al. Erbium: YAG laser (2,940 nm) treatment stimulates hair growth through upregulating Wnt 10b and β catenin expression in C57BL/6 mice // International Journal of Clinical and Experimental Medicine.– 2015.– V. 8.– № . 11.– P. 20883.</mixed-citation><mixed-citation xml:lang="en">Ke J. et al. Erbium: YAG laser (2,940 nm) treatment stimulates hair growth through upregulating Wnt 10b and β catenin expression in C57BL/6 mice // International Journal of Clinical and Experimental Medicine.– 2015.– V. 8.– № . 11.– P. 20883.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dabek R.J., Austen Jr W.G., Bojovic B. Laser assisted hair regrowth: fractional laser modalities for the treatment of androgenic alopecia // Plastic and Reconstructive Surgery–Global Open.– 2019.– V. 7.– № . 4.– P. e2157.</mixed-citation><mixed-citation xml:lang="en">Dabek R.J., Austen Jr W.G., Bojovic B. Laser assisted hair regrowth: fractional laser modalities for the treatment of androgenic alopecia // Plastic and Reconstructive Surgery–Global Open.– 2019.– V. 7.– № . 4.– P. e2157.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y., Zhuo F., Li L. Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors //Lasers in medical science.– 2017.– V. 32.– № . 8.– P. 1711–1718.</mixed-citation><mixed-citation xml:lang="en">Huang Y., Zhuo F., Li L. Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors //Lasers in medical science.– 2017.– V. 32.– № . 8.– P. 1711–1718.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lee G.Y., Lee S.J., Kim W.S. The effect of a 1550 nm fractional erbium–glass laser in female pattern hair loss // Journal of the European Academy of Dermatology and Venereology.–2011.– V. 25.– № . 12.– P. 1450–1454.</mixed-citation><mixed-citation xml:lang="en">Lee G.Y., Lee S.J., Kim W.S. The effect of a 1550 nm fractional erbium–glass laser in female pattern hair loss // Journal of the European Academy of Dermatology and Venereology.–2011.– V. 25.– № . 12.– P. 1450–1454.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ito M. et al. Wnt dependent de novo hair follicle regeneration in adult mouse skin after wounding // Nature.– 2007.– V. 447.– № . 7142.– P. 316–320.</mixed-citation><mixed-citation xml:lang="en">Ito M. et al. Wnt dependent de novo hair follicle regeneration in adult mouse skin after wounding // Nature.– 2007.– V. 447.– № . 7142.– P. 316–320.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart N. et al. Lasers and laser like devices: Part one // Australasian Journal of Dermatology.– 2013.– V. 54.– № . 3.– P. 173–183.</mixed-citation><mixed-citation xml:lang="en">Stewart N. et al. Lasers and laser like devices: Part one // Australasian Journal of Dermatology.– 2013.– V. 54.– № . 3.– P. 173–183.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cho S.B. et al. Therapeutic efficacy and safety of a 1927 nm fractionated thulium laser on pattern hair loss: an evaluator blinded, split scalp study // Lasers in Medical Science.–2018.– V. 33.– P. 851–859.</mixed-citation><mixed-citation xml:lang="en">Cho S.B. et al. Therapeutic efficacy and safety of a 1927 nm fractionated thulium laser on pattern hair loss: an evaluator blinded, split scalp study // Lasers in Medical Science.–2018.– V. 33.– P. 851–859.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Martínez Pascual M. A. et al. Effects of RF Electric Currents on Hair Follicle Growth and Differentiation: A Possible Treatment for Alopecia // International Journal of Molecular Sciences.– 2024.– V. 25.– № . 14.– P. 7865.</mixed-citation><mixed-citation xml:lang="en">Martínez Pascual M. A. et al. Effects of RF Electric Currents on Hair Follicle Growth and Differentiation: A Possible Treatment for Alopecia // International Journal of Molecular Sciences.– 2024.– V. 25.– № . 14.– P. 7865.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hernández Bule M. L. et al. Electric stimulation at 448 kHz promotes proliferation of human mesenchymal stem cells //Cellular Physiology and Biochemistry.– 2014.– V. 34.– № . 5.– P. 1741–1755.</mixed-citation><mixed-citation xml:lang="en">Hernández Bule M. L. et al. Electric stimulation at 448 kHz promotes proliferation of human mesenchymal stem cells //Cellular Physiology and Biochemistry.– 2014.– V. 34.– № . 5.– P. 1741–1755.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Toledano Macías E., Martínez Pascual M. A., Hernández Bule M.L. Electric currents of 448 kHz upregulate ant senescence pathways in human dermal fibroblasts // Journal of Cosmetic Dermatology.– 2024.– V. 23.– № . 2.– P. 687–700.</mixed-citation><mixed-citation xml:lang="en">Toledano Macías E., Martínez Pascual M. A., Hernández Bule M.L. Electric currents of 448 kHz upregulate ant senescence pathways in human dermal fibroblasts // Journal of Cosmetic Dermatology.– 2024.– V. 23.– № . 2.– P. 687–700.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nirmal B., Mubeena S.S., Antonisamy B. Efficacy and safety of microneedling radiofrequency in patterned hair loss // Journal of Cutaneous and Aesthetic Surgery.– 2024.– V. 17.– № . 3.– P. 189.</mixed-citation><mixed-citation xml:lang="en">Nirmal B., Mubeena S.S., Antonisamy B. Efficacy and safety of microneedling radiofrequency in patterned hair loss // Journal of Cutaneous and Aesthetic Surgery.– 2024.– V. 17.– № . 3.– P. 189.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon S. Y. et al. Induction of hair growth by insulin like growth factor 1 in 1,763 MHz radiofrequency irradiated hair follicle cells // PloS one.– 2011.– V. 6.– № . 12.– P. e28474.</mixed-citation><mixed-citation xml:lang="en">Yoon S. Y. et al. Induction of hair growth by insulin like growth factor 1 in 1,763 MHz radiofrequency irradiated hair follicle cells // PloS one.– 2011.– V. 6.– № . 12.– P. e28474.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Verner I., Lotti T. Clinical evaluation of a novel fractional radiofrequency device for hair growth: fractional radiofrequency for hair growth stimulation // Dermatologic Therapy.–2018.– V. 31.– № . 3.– P. e12590.</mixed-citation><mixed-citation xml:lang="en">Verner I., Lotti T. Clinical evaluation of a novel fractional radiofrequency device for hair growth: fractional radiofrequency for hair growth stimulation // Dermatologic Therapy.–2018.– V. 31.– № . 3.– P. e12590.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
